Zoledronic acid shows no effect on knee pain or bone marrow lesions in knee osteoarthritis after two years
Some symptomatic benefit was seen in patients with milder disease The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) show that a one-yearly infusion of zoledronic acid (ZA) did not significantly reduce knee pain or bone marrow lesion (BML)…